Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) General Counsel Philip Mazzara sold 50,000 shares of Astera Labs stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $87.46, for a total value of $4,373,000.00. Following the completion of the transaction, the general counsel now owns 191,209 shares of the company’s stock, valued at $16,723,139.14. The trade was a 20.73 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
Philip Mazzara also recently made the following trade(s):
- On Tuesday, February 18th, Philip Mazzara sold 7,536 shares of Astera Labs stock. The shares were sold at an average price of $92.07, for a total value of $693,839.52.
Astera Labs Stock Down 3.1 %
ALAB opened at $85.72 on Friday. The firm has a market cap of $13.90 billion and a price-to-earnings ratio of -49.55. Astera Labs, Inc. has a 52 week low of $36.22 and a 52 week high of $147.39. The business’s 50 day moving average is $116.72 and its two-hundred day moving average is $84.84.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in the company. Whittier Trust Co. of Nevada Inc. purchased a new position in shares of Astera Labs in the 4th quarter valued at approximately $25,000. Hollencrest Capital Management purchased a new position in shares of Astera Labs in the 3rd quarter valued at approximately $26,000. Steward Partners Investment Advisory LLC grew its stake in shares of Astera Labs by 99.0% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company’s stock valued at $26,000 after purchasing an additional 99 shares during the last quarter. Kestra Investment Management LLC purchased a new position in shares of Astera Labs in the 4th quarter valued at approximately $28,000. Finally, Geneos Wealth Management Inc. purchased a new position in shares of Astera Labs in the 4th quarter valued at approximately $36,000. Institutional investors and hedge funds own 60.47% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on ALAB shares. Citigroup started coverage on Astera Labs in a research note on Monday, November 18th. They issued a “buy” rating and a $120.00 price objective for the company. Barclays lifted their price objective on Astera Labs from $87.00 to $135.00 and gave the company an “overweight” rating in a research note on Friday, January 17th. Northland Capmk upgraded Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 28th. Morgan Stanley cut their target price on Astera Labs from $142.00 to $114.00 and set an “equal weight” rating on the stock in a research report on Tuesday, January 28th. Finally, Needham & Company LLC reissued a “buy” rating and set a $140.00 target price on shares of Astera Labs in a research report on Tuesday, February 11th. One equities research analyst has rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Astera Labs has an average rating of “Buy” and an average price target of $115.33.
Get Our Latest Stock Report on Astera Labs
Astera Labs Company Profile
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
See Also
- Five stocks we like better than Astera Labs
- How to Use the MarketBeat Dividend Calculator
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- The Basics of Support and Resistance
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- What is the Dogs of the Dow Strategy? Overview and Examples
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.